Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes

NCT07541456 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
300
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dr. Zarmina Younes